Key Record Dates
ClinicalTrials.gov Identifier: | NCT05986240 |
---|---|
Brief Title: | Danvatirsen Monotherapy Followed by Combination With Venetoclax in Relapsed/Refractory MDS & AML |
First Submitted : | August 1, 2023 |
First Submitted that Met QC Criteria : | August 1, 2023 |
First Posted : | August 14, 2023 |
Last Update Submitted that Met QC Criteria : | May 8, 2024 |
Last Update Posted : | May 9, 2024 |